Congress Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $317K | Sell |
|
|||||
|
2024
Q3 | $280K | Sell |
|
|||||
|
2024
Q2 | $243K | Sell |
|
|||||
|
2024
Q1 | $35.2M | Buy |
|
|||||
|
2023
Q4 | $26.6M | Buy |
|
|||||
|
2023
Q3 | $25.3M | Buy |
|
|||||
|
2023
Q2 | $23.1M | Buy |
|
|||||
|
2023
Q1 | $20.3M | Buy |
|
|||||
|
2022
Q4 | $18.1M | Sell |
|
|||||
|
2022
Q3 | $17.2M | Buy |
|
|||||
|
2022
Q2 | $13.9M | Buy |
|
|||||
|
2022
Q1 | $15M | Buy |
|
|||||
|
2021
Q4 | $11.6M | Buy |
|
|||||
|
2021
Q3 | $8.37M | Buy |
|
|||||
|
2021
Q2 | $9.08M | Buy |
|